Nicholas McGrane, Chief Financial Officer at Evolent Health, Inc. (EVH), sold 1,667 shares at $25.42 ($42K) on 2017-07-10, disclosed to the SEC on 2017-07-12.
Scheduled sale ($42k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EVH | SELL | 2017-05-23 | $2.3M | — | Filing → |
| EVH | SELL | 2017-05-12 | $40K | — | Filing → |
| EVH | SELL | 2017-04-21 | $38K | — | Filing → |